Metraipolis › archive › dc_381fa8cd3d8e

Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a… — Europe PMC PMID:41501026

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41501026
DOI
10.1038/s41467-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-07T00:39:43.106Z
SHA-256 of the archived text
46fddd7bf749f8775272c968776e51571509f53da279860c3383dbfb8949103c
Stable URL of this page
https://metraipolis.com/documento/dc_381fa8cd3d8e

How to cite

Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a… — Europe PMC PMID:41501026 — Europe PMC (en), https://europepmc.org/article/MED/41501026 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_381fa8cd3d8e (Metraipolis archive dc_381fa8cd3d8e, sha256 46fddd7bf749f8775272c968776e51571509f53da279860c3383dbfb8949103c)
BibTeX
@misc{dc381fa8cd3d8e,
  title = {Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a… — Europe PMC PMID:41501026},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41501026},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_381fa8cd3d8e; sha256 46fddd7bf749f8775272c968776e51571509f53da279860c3383dbfb8949103c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41501026. Agents can read the archived copy with the MCP tool read_document.